Adding these inhibitors to immunotherapy increases the risk of thyroid dysfunction, especially in patients who already have autoantibodies against this organ.
Scientists from Nagoya University have found that the use of tyrosine kinase inhibitors (TKIs) in combination with anti-PD-L1 drugs is associated with greater thyroid toxicity compared with anti-PD-L1 monotherapy. In more than 700 patients who received either regimen, the incidence of … + read more
According to the Spanish Society of Medical Oncology (SEOM), about 6,000 new cases of thyroid cancer will be diagnosed in 2023. + more
Thyroid cancer is the ninth most common tumor in the world; an estimated 6,000 new cases will be diagnosed in Spain in 2023. + more
Combination therapy provides 78% disease control in patients with multiple prior treatments and metastatic disease. + read more
A link has been found between certain per- and polyfluoroalkyl substances (PFAS) and an increased risk of thyroid cancer, thus documenting what was until now a hypothesis. + read more
CMT is one of the rarest forms of thyroid cancer, accounting for approximately three percent of all cases. + read more
Antiangiogenic therapy in patients with osimertinib-resistant tumors is more effective than immunotherapy or chemotherapy. + read more
Cher Cher and her son Chaz at the "Little Bites" premiere at Past Fest. (Photo…
After a fierce overnight bombardment of northern Gaza, the Israeli army has launched a new…
Twelve people have already died from the Marburg virus in RwandaTo date, 46 people have…
After more than 30 years of agreement Nestlé and Coca-Cola are ending their trade agreement.…
Meta, parent company whatsapp, Facebook And instagramannounced that it will update its instant messaging application…
Marc Márquez had problems throughout the season with the brakes on his Ducati, which increased…